C4 Therapeutics, Inc. (CCCC)
2.93
-0.04
(-1.35%)
USD |
NASDAQ |
May 06, 16:00
2.92
-0.01
(-0.34%)
After-Hours: 20:00
C4 Therapeutics Shareholders Equity (Quarterly) : 256.59M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 90.10B |
| Biogen, Inc. | 18.65B |
| Merck & Co., Inc. | 45.88B |
| Bristol Myers Squibb Co. | 20.07B |
| BrightSpring Health Services, Inc. | 1.979B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 371.94M |
| Total Liabilities (Quarterly) | 115.35M |
| Debt to Equity Ratio | 0.2338 |
| Current Ratio | 7.814 |
| Net Debt Paydown Yield | 0.77% |